# Smoking Cessation Treatment for Head and Neck Cancer Patients

> **NCT00931021** · EARLY_PHASE1 · TERMINATED · sponsor: **Yale University** · enrollment: 7 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Varenicline (Chantix)
- **DRUG:** Nicotine Patch

## Key facts

- **NCT ID:** NCT00931021
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2013-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931021, "Smoking Cessation Treatment for Head and Neck Cancer Patients". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00931021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*